Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-014087
Filing Date
2013-03-04
Accepted
2013-03-04 17:09:54
Documents
1
Period of Report
2013-02-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd372707.html 3  
1 FORM 3 rrd372707.xml 3 3153
  Complete submission text file 0001181431-13-014087.txt   4710
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Issuer) CIK: 0001070336 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036 212-705-8800
QVT Associates GP LLC (Reporting) CIK: 0001290166 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-33095 | Film No.: 13662646